BioNTech BNTX
$80.96 −$0.42 (-0.52%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $81.00 +0.05%
Open$80.82
Prev close$81.38
Day range$80.27 – $82.87
Volume1.71M
Market cap$20.07B
P/E (TTM)–
Dividend yield–
BNTX Stock News
Headlines matching BioNTech or the BNTX ticker, most recent first.
- BMO Capital Downgrades BioNTech(BNTX.US) to Hold Rating, Cuts Target Price to $105 Negative
- Goldman Sachs Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $127 Negative
- BioNTech(BNTX.US) 10% Shareholder Sells US$6.01 Million in Common Stock
- Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $115
- BioNTech(BNTX.US) 10% Shareholder Sells US$6.84 Million in Common Stock
- Wells Fargo Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $140
- CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $136
- UBS Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $135
- A Quick Look at Today's Ratings for BioNTech(BNTX.US), With a Forecast Between $135 to $140
- BofA Securities Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $122
- Evercore Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $130
- Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $115 Negative
- Citi Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $125
- CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $136 Negative
- BMO Capital Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $128
No comments yet — be the first to weigh in on BNTX.
Sign in to join the discussion.